3篇
您的检索式：作者名="Reham Soliman"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Correlation between corneal demarcation line depth in epithelium-off and trans-epithelium accelerated corneal cross linking and keratoconus progression显示文摘AIM:To compare corneal demarcation line(DL)depth in both accelerated epithelium-off and trans-epithelium cross linking(CXL)using anterior segment optical coherence tomography(AS-OCT)and its relation to maximum keratometry(Kmax)progression in both techniques.METHODS:A prospective comparative interventional study where patients with mild to moderate keratoconus(KC)were classified into two groups:accelerated epitheliumoff and trans-epithelium CXL based on corneal pachymetry.Assessment of corneal DL depth was carried out after 3mo by AS-OCT.Kmax readings were evaluated after one year follow up using the Scheimpflug imaging system.RESULTS:Study included 74 eyes of 44 patients.Group A underwent epithelium-off CXL(41 eyes),while Group B underwent trans-epithelium CXL(33 eyes).At 3mo follow up,mean corneal DL depth in Group A was 219.9±58.4μm while in Group B was 127.2±7.8μm(P<0.05).The mean Kmaxchangedfrom51.9±3.9to51.3±4.2dioptersin Group A and from 53.1±4.1 to 53.6±5 diopters in Group B with insignificant difference in Kmax changes in either group(P>0.05).In addition,no significant change in corneal pachymetry was found in both groups(meanchange at 1y:6.4±4.7 and-10.1±2.3μm in Groups A and B respectively).CONCLUSION:Despite a significantly deeper corneal DL depth created by accelerated epithelium-off CXL technique compared to accelerated trans-epithelium CXL,there is no significant impact on keratoconus progression. | Mahmoud Abdel-Radi Zeiad Eldaly Hazem Abdelmotaal Reham Abdelrahman Mohamed Sayed Kamel Soliman | 2020 | International Journal of Ophthalmology(English edition)2020，13，6： | 2 |
| 2 | Pattern of clinical presentation of congenital anomalies of the kidney and urinary tract among infants and children显示文摘 | Neveen A Soliman Reham I Ali Emad E Ghobrial Enmar I Habib Ali M Ziada | 2015 | Nephrology2015，，6： | 1 |
| 3 | Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients:a prospective observational study显示文摘Aim:Studies of clinical outcomes in chronic hepatitis C(CHC)patients with pretreatment advanced liver fibrosis(F3)after sustained virologic response(SVR)are scarce,and most studies are of small cohorts and retrospective in nature.Our aim was to assess the clinical outcomes following direct acting antiviral(DAA)treatment among hepatitis C F3 patients after SVR.Methods:This study included 1517 chronic hepatitis C patients with F3 fibrosis receiving DAAs in the out-patient clinics at the Egyptian Liver Research Institute and Hospital(ELRIAH).We included patients 18 years or older with HCV who received DAAs,have F3 by transient elastography,and have no history of hepatocellular carcinoma(HCC).Patients were followed up every six months after end of treatment using ultrasonography and AFP.Results:Significant improvement of fibrosis occurred with decreases in LSM,FIB-4,APRI,and FIB-6.When changes in LSM were categorized depending on delta LSM,873 patients(57.5%)showed regression,454(29.9%)were stable,and 190 patients(12.5%)showed progression of fibrosis.Overall,33 cases developed HCC during follow-up with incidence rate of 0.915/100 py(95%CI:0.64-1.27).Incidence was high with progression of liver fibrosis(6.17/100 py)compared to patients with stable fibrosis(1.09/100 py)and regression of liver fibrosis(0.75/100 py).There were no significant differences as regards fibrosis indicators at baseline(LSM,FIB-4,APRI,and FIB-6)between those who developed HCC and those who did not.Conclusion:CHC Patients with F3 fibrosis showed a high rate of regression of fibrosis and decreased HCC incidence after achieving SVR following DAAs. | Gamal Shiha Reham Soliman Ayman AHassan Nabiel N.H.Mikhail | 2022 | Hepatoma Research2022，8，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员